Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29552244 | 0.99 | INPPL1 (0.33) | INPPL1INPP5A | |
| Ammonia Solution, Strong SCHEMBL1868933 | 0.99 | INPPL1 (0.33) | INPPL1INPP5A | |
| Ammonia Solution, Strong SCHEMBL1868935 | 0.99 | INPPL1 (0.33) | INPPL1INPP5A | |
| SCHEMBL20777534 | 0.84 | GLA (0.33) | — | |
| Phosphoric Acid SCHEMBL3417079 | 0.83 | — | — | |
| SCHEMBL18634052 | 0.82 | ALDH1A1 (0.32) | — | |
| SCHEMBL29931019 | 0.80 | PDE3B (0.31) | — | |
| SCHEMBL29446026 | 0.78 | CASP3 (0.35) | — | |
| SCHEMBL16616806 | 0.77 | ALDH1A1 (0.33) | — | |
| SCHEMBL30433736 | 0.77 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10605803-B2 | Composition for enzyme immunoassay using immunofluorescence and uses thereof | BIOMERIEUX (FR) | 2020-03-31 | — | — | US | claimed |
| EP-3207371-B1 | COMPOSITION FOR ENZYME IMMUNOASSAY USING IMMUNOFLUORESCENCE AND USES THEREOF | BIOMERIEUX SA (FR) | 2018-12-12 | — | — | EP | claimed |
| US-20170241994-A1 | COMPOSITION FOR ENZYME IMMUNOASSAY USING IMMUNOFLUORESCENCE AND USES THEREOF | BIOMERIEUX (FR) | 2017-08-24 | — | — | US | claimed |
| EP-3207371-A1 | COMPOSITION FOR ENZYME IMMUNOASSAY USING IMMUNOFLUORESCENCE AND USES THEREOF | Biomérieux (FR) | 2017-08-23 | — | — | EP | claimed |
| WO-2016059351-A1 | COMPOSITION FOR ENZYME IMMUNOASSAY USING IMMUNOFLUORESCENCE AND USES THEREOF | bioMérieux (FR) | 2016-04-21 | — | — | WO | claimed |
| US-20140349893-A1 | LABELING OF IMMOBILIZED PROTEINS USING DIPYRROMETHENEBORON DIFLUORIDE DYES | Life Technologies Corporation (US) | 2014-11-27 | — | — | US | claimed |
| US-20130288270-A1 | CHEMILUMINESCENT ENZYME ASSAY METHOD AND APPARATUS | LUMINESCENT MD. LLC (US) | 2013-10-31 | — | — | US | claimed |
| EP-1725676-B1 | MEASURING CONTAMINATION | MYCOMETER AS (DK) | 2012-04-25 | — | — | EP | claimed |
| JP-4643262-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| JP-4643263-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| WO-2004020604-A2 | ALLELE SPECIFIC PRIMER EXTENSION | AMERSHAM BIOSCIENCES CORP (US) | 2004-03-11 | — | — | WO | claimed |
| US-20040048301-A1 | Allele specific primer extension | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2004-03-11 | — | — | US | claimed |
| WO-2004020603-A2 | ANALYTE DETECTION | AMERSHAM BIOSCIENCES CORP (US) | 2004-03-11 | — | — | WO | claimed |
| US-20030162213-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-08-28 | — | — | US | claimed |
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-07-03 | — | — | US | claimed |
| US-20030096253-A1 | Single nucleotide amplification and detection by polymerase | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-05-22 | — | — | US | claimed |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-04-24 | — | — | US | claimed |
| WO-2003020984-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES AND METHODS OF USE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020891-A2 | SINGLE NUCLEOTIDE AMPLIFICATION AND DETECTION BY POLYMERASE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020734-A2 | LABELED NUCLEOSIDE POLYPHOSPHATES | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | PNP, RNGTT, MTAP | INPPL1 44/4885INPP5A 155/4885 |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | RNGTT, DNTT, PNP | INPPL1 69/4885INPP5A 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.